The government said that people aged 60 and older could receive a fourth dose of the Covid-19 vaccine from Thursday.Health authorities will provide the second boosters using mRNA (messenger ribonucleic acid) vaccines, such as Pfizer and Moderna, for older adults who have surpassed 120 days after rec
Boditech Med said it obtained the regulatory nod for ichorma Vitamin D Neo, a diagnostic device that can detect Vitamin-D deficiency in blood in 12 minutes.The device’s identification of Vitamin D levels within 12 minutes at a medical institution will reduce the inconvenience of patients who otherwi
RedHill Biopharma’s investigational Covid-19 treatment opaganib is effective against the Omicron variant, an in vitro study said. Attention is on whether the study results will benefit Kukbo, which licensed in the oral Covid-19 treatment from RedHill Biopharma.The Israel-based biopharmaceutical comp
Theragen Bio said Wednesday that the company has launched Hellogene 4.0, its newest disease prediction personal genetic test service.Hellogene 4.0 is a disease prediction genetic test that allows a medical institution to request a genetic test after collecting a patient's blood, providing it to Ther
Celltrion said it has released the phase 3 clinical trial results of CT-P16, a biosimilar for Avastin (ingredient: bevacizumab), at the American Association for Cancer Research 2022 (AACR).AACR is an international cancer association with over 40,000 members from 120 countries. This year, the meeting
The Ministry of Food and Drug Safety (MFDS) refused the request from the pharmaceutical industry to allow the indirect export of botulinum toxin (BTX) products through agencies.On Tuesday, Jeong Hyeon-cheol, director of the Biopharmaceutical Policy Division at the MFDS, said in a meeting with report
AstraZeneca (AZ) said its new anti-cancer drug candidate MEDI5752, a bispecific antibody targeting PD-1 and CTLA-4 simultaneously, showed a promising potential to overcome the toxicity of AZ’s CTLA-1 inhibitor tremelimumab in the first clinical trial.Dr. Ben Tran at the Peter MacCallum Cancer Centre
SK Bioscience will develop a new drug that prevents infections, such as the Covid-19 virus, by spraying antiviral protein into the nose.The company said Wednesday that it would cooperate with overseas research institutes, such as the International AIDS Vaccine Initiative (IAVI) and the University of
Kolon TissueGene's Invossa, the world's first osteoarthritis cell gene therapy, may get back on track as the company successfully licensed the drug to a foreign biopharmaceutical firm.Kolon Life Science, the parent company of Kolon Tissuegene, said Wednesday that it had signed a technology export co
Health officials said that Korea has confirmed the first case of XL, a recombinant of the Omicron Covid-19 strain.A recombinant variant occurs when an individual simultaneously becomes infected with two or more variants. The XL is one of 17 recombinant variants involving the BA.1 and BA.2 Omicron st
LG Chem is gearing up to enter the Chinese market with a premium hyaluronic acid filler brand.On Thursday, the Korean chemical company updated the status of the clinical trial of YVOIRE Y-Solution 360 to “recruiting,” according to ClinicalTrials.gov, a registry of clinical trials run by the U.S. Nat
3billion, a rare disease genetic test developer, said it would enter the U.S. market in earnest.The Korean company obtained the College of American Pathologists (CAP) certification in November and recently raised 13.1 billion won ($10.5 million) pre-IPO funding to tap the global diagnostic market.Th
Amgen’s first KRAS targeted therapy, Lumakras (ingredient: sotorasib), demonstrated consistent clinical benefits in the longest follow-up of patients with KRAS G12C-mutated non-small cell lung cancer (NSCLC).On Sunday, Amgen released the two-year data of the CodeBreak100 phase 1/2 trial of Lumakras
“We cannot answer your question as we have to ask our global headquarters for comment and win their approval. Can you give us the question you want to ask in a document so we can ask our headquarters?”That was the response from a spokesperson for Janssen Korea, the local offshoot of Johnson & Johnso
Novartis Korea aims to address the unmet needs of non-small cell lung cancer (NSCLC) patients with MET exon 14 skipping mutation with the launch of Tabrecta, the company said Tuesday."Lung cancer is the third most common cancer in Korea, and NSCLC has a five-year relative survival rate of only 8.9 p
Researchers at the Korea Advanced Institute of Science and Technology (KAIST) have developed genome alignment software that uses a machine learning-based learned-index technique for the first time.Next-generation sequencing (NGS) is a method of deciphering genome information, in which the genome is
Yuyu Pharmaceutical said that it has received approval from the U.S. Food and Drug Administration to conduct phase 2 clinical trials for YP-P10, a new dry eye treatment.YP-P10 is a new biopharmaceutical using synthetic peptides and aims to relieve signs and symptoms of dry eye syndrome caused by inf
Zuellig Pharma Korea fell to full-scale capital erosion for the second year as its liabilities exceeded assets due to continued losses in 2021.Complete capital erosion refers to a situation in which the total amount of capital for a company goes below zero as the company's deficit widens, surplus ru
The government has set about discussions on overhauling the current social distancing steps, which restrict private gatherings to 10 people and business hours to midnight, effective until this weekend.“We have entered into a discussion about what to do with the entire social distancing system, inclu
Yuhan Corp. said that its U.S. partner Spine Biopharma has received approval from the U.S. Food and Drug Administration for the phase 3 clinical trial of YH14618, a degenerative disc treatment candidate.Spine Biopharma plans to start trials in June and obtain results by the first half of 2024.YH1461